Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 42 articles: HTML format

Single Articles

May 2024
1. VOICHANSKI S, Bousquet E, Abraham N, Santina A, et al
   En Face Optical Coherence Tomography Illustrates the Trizonal Distribution of Drusen and Subretinal Drusenoid Deposits in the Macula.
   Am J Ophthalmol. 2024;261:187-198.
   PubMed     Abstract available
   
   
   April 2024
2. WAI KM, Mishra K, Koo E, Ludwig CA, et al
   Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
   Am J Ophthalmol. 2024 Apr 16:S0002-9394(24)00150.
   PubMed     Abstract available
   
   
   March 2024
3. JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
   Diagnostic accuracy of artificial intelligence based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.
   Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
   PubMed     Abstract available
   
   
   February 2024
4. DAI Y, Zheng D, Zhao J, Wang K, et al
   Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study.
   Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
   PubMed     Abstract available
   
   
   November 2023
5. DANZINGER V, Schartmuller D, Lisy M, Schranz M, et al
   Intraindividual Comparison Of An Enhanced Monofocal And An Aspheric Monofocal Intraocular Lens Of The Same Platform.
   Am J Ophthalmol. 2023 Nov 7:S0002-9394(23)00463.
   PubMed     Abstract available
   
   
   September 2023
6. TSAI WS, Thottarath S, Gurudas S, Pearce E, et al
   Topographic Correlation of Microperimetry with Structural Characteristics in Diabetic Macular Ischemia.
   Am J Ophthalmol. 2023 Sep 13:S0002-9394(23)00363.
   PubMed     Abstract available
   
   
   
7. RAMESH S, Zhang QE, Sharpe J, Penne R, et al
   Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.
   Am J Ophthalmol. 2023;253:74-85.
   PubMed     Abstract available
   
   
   August 2023
8. SINGER M, O'Brien P, Mein L
   CORNEAL SENSITIVITY IS INVERSELY CORRELATED WITH SEVERITY OF DIABETIC RETINOPATHY IN A PREDOMINANTLY UNDERREPRESENTED POPULATION.
   Am J Ophthalmol. 2023 Aug 27:S0002-9394(23)00339.
   PubMed     Abstract available
   
   
   July 2023
9. VALLURU G, Costa A, Klawe J, Liu B, et al
   Depression in Individuals with Diabetic Retinopathy in the US NHANES, 2005-2008.
   Am J Ophthalmol. 2023 Jul 24:S0002-9394(23)00285.
   PubMed     Abstract available
   
   
   
10. WYKOFF CC, Garweg JG, Regillo C, Souied E, et al
    KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema.
    Am J Ophthalmol. 2023 Jul 15:S0002-9394(23)00291.
    PubMed     Abstract available
    
    
    June 2023
11. YILMAZ YC, Hayat SC, Ipek SC
    Analysis of Corneal and Lens Densitometry Changes in the Type 1 Diabetes Mellitus Patients.
    Am J Ophthalmol. 2023 Jun 1:S0002-9394(23)00222.
    PubMed     Abstract available
    
    
    May 2023
12. MERRILL PT, Holekamp N, Roth D, Kasper J, et al
    Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].
    Am J Ophthalmol. 2023 May 22:S0002-9394(23)00194.
    PubMed    
    
    
    April 2023
13. HUANG Y, Yuan Y, Seth I, Bulloch G, et al
    Optic nerve head capillary network quantified by OCTA and progressive eGFR decline in type 2 diabetes: A three-year prospective study.
    Am J Ophthalmol. 2023 Apr 12:S0002-9394(23)00168.
    PubMed     Abstract available
    
    
    
14. BANDELLO F, Borrelli E, Trevisi M, Lattanzio R, et al
    Imaging Biomarkers of Mesopic and Dark-adapted Macular Functions in Eyes with Treatment-Naive Mild Diabetic Retinopathy.
    Am J Ophthalmol. 2023 Apr 12:S0002-9394(23)00166.
    PubMed     Abstract available
    
    
    March 2023
15. CHEN Y, Wang W
    Reply to Comment on "Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort".
    Am J Ophthalmol. 2023 Mar 29:S0002-9394(23)00131.
    PubMed    
    
    
    
16. GOVINDARAJ I, Selvister SM, Rajendran A
    Comment on " Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort".
    Am J Ophthalmol. 2023 Mar 28:S0002-9394(23)00130.
    PubMed    
    
    
    
17. VANDER JF, Fineman MS, Garg S, Regillo CD, et al
    Comment on: Perspective: A caveat about financial incentives for anti-vascular endothelial growth factor therapy for diabetic retinopathy.
    Am J Ophthalmol. 2023 Mar 3:S0002-9394(23)00077.
    PubMed    
    
    
    
18. YOUNG BK, Hwang M, Johnson MW, Besirli CG, et al
    Response to "Comment on: Perspective: A caveat about financial incentives for anti-vascular endothelial growth factor therapy for diabetic retinopathy".
    Am J Ophthalmol. 2023 Mar 2:S0002-9394(23)00078.
    PubMed    
    
    
    January 2023
19. YOUNG BK, Hwang M, Johnson MW, Besirli CG, et al
    Reply to Comment on "A Caveat about Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy.".
    Am J Ophthalmol. 2023 Jan 17:S0002-9394(23)00015.
    PubMed    
    
    
    
20. GOSALA S
    "Comment on" Caveat About Financial Incentives For Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy.
    Am J Ophthalmol. 2023 Jan 14:S0002-9394(23)00014.
    PubMed    
    
    
    
21. YIU G, Huang D, Wang Y, Wang Z, et al
    Predictors of As-Needed Ranibizumab Injection Frequency in Patients with Macular Edema Following Retinal Vein Occlusion.
    Am J Ophthalmol. 2023 Jan 13:S0002-9394(23)00009.
    PubMed     Abstract available
    
    
    December 2022
22. LEE CS, Krakauer C, Su YR, Walker R, et al
    Diabetic Retinopathy and Dementia Association, Beyond Diabetes Severity.
    Am J Ophthalmol. 2022 Dec 10:S0002-9394(22)00486.
    PubMed     Abstract available
    
    
    November 2022
23. CHEN Y, Zhu Z, Cheng W, Bulloch G, et al
    Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort: Choriocapillaris flow predicts DR progression and DME development.
    Am J Ophthalmol. 2022 Nov 24:S0002-9394(22)00449.
    PubMed     Abstract available
    
    
    
24. HE Y, Verma A, Nittala MG, Velaga SB, et al
    Ethnic Variation in Diabetic Retinopathy Lesion Distribution on Ultra-widefield Imaging.
    Am J Ophthalmol. 2022 Nov 8. pii: S0002-9394(22)00422.
    PubMed     Abstract available
    
    
    October 2022
25. MERRILL PT, Holekamp N, Roth D, Kasper J, et al
    The 0.19-mg fluocinolone acetonide intravitreal implant reduces treatment burden in diabetic macular edema.
    Am J Ophthalmol. 2022 Oct 9. pii: S0002-9394(22)00374.
    PubMed     Abstract available
    
    
    August 2022
26. MEHRA AA, Softing A, Guner MK, Hodge DO, et al
    Diabetic Retinopathy Telemedicine Outcomes with Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread.
    Am J Ophthalmol. 2022 Aug 12. pii: S0002-9394(22)00310.
    PubMed     Abstract available
    
    
    
27. ISRAELI A, Peer H, Gleitman I, Falick Y, et al
    Time Trends of Etiologies of Blindness in Israel 2009-2020:Have Methods to Decrease Leading Causes of Blindness Been Exhausted?
    Am J Ophthalmol. 2022;240:149-158.
    PubMed     Abstract available
    
    
    July 2022
28. YOUNG BK, Hwang M, Johnson MW, Besirli CG, et al
    A Caveat about Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy.
    Am J Ophthalmol. 2022 Jul 25. pii: S0002-9394(22)00282.
    PubMed     Abstract available
    
    
    
29. HUANG Y, Zhang N, Bulloch G, Zhang S, et al
    Rates of choroidal and neurodegenerative changes over time in diabetic patients without retinopathy: a 3-year prospective study.
    Am J Ophthalmol. 2022 Jul 20. pii: S0002-9394(22)00273.
    PubMed     Abstract available
    
    
    
30. GUO X, Chen Y, Bulloch G, Xiong K, et al
    Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study.
    Am J Ophthalmol. 2022 Jul 18. pii: S0002-9394(22)00270.
    PubMed     Abstract available
    
    
    
31. YUAN M, Wang W, Kang S, Li Y, et al
    Peripapillary Microvasculature Predicts the Incidence and Development of Diabetic Retinopathy: An SS-OCTA Study.
    Am J Ophthalmol. 2022 Jul 15. pii: S0002-9394(22)00260.
    PubMed     Abstract available
    
    
    
32. O'BRYHIM BE, Samara A, Chen L, Hershey T, et al
    Longitudinal Changes in Vision and Retinal Morphological in Wolfram Syndrome.
    Am J Ophthalmol. 2022 Jul 15. pii: S0002-9394(22)00262.
    PubMed     Abstract available
    
    
    June 2022
33. RUSH RB, Velazquez JC, Rosales CR, Rush SW, et al
    Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging after Diabetic Vitrectomy: a Randomized Clinical Trial: Gas versus Fluid after Diabetic Vitrectomy.
    Am J Ophthalmol. 2022 Jun 25. pii: S0002-9394(22)00251.
    PubMed     Abstract available
    
    
    
34. SOBRIN L, Susarla G, Stanwyck L, Rouhana JM, et al
    Erratum to Gene Set Enrichment Analyses Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy. Am J Ophthalmol 2022;233:111-123.
    Am J Ophthalmol. 2022 Jun 1. pii: S0002-9394(22)00090.
    PubMed    
    
    
    April 2022
35. BARBONI P, Amore G, Cascavilla ML, Battista M, et al
    The pattern of retinal ganglion cell loss in Wolfram syndrome is distinct from mitochondrial optic neuropathies.
    Am J Ophthalmol. 2022 Apr 19. pii: S0002-9394(22)00119.
    PubMed     Abstract available
    
    
    January 2022
36. CHAI YH, Zhang YP, Qiao YS, Gong HJ, et al
    Association between diabetic retinopathy, brain structural abnormalities and cognitive impairment for accumulated evidence in observational studies.
    Am J Ophthalmol. 2022 Jan 18. pii: S0002-9394(22)00012.
    PubMed     Abstract available
    
    
    
37. BROWN DM, Emanuelli A, Bandello F, Barranco JJE, et al
    KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema.
    Am J Ophthalmol. 2022 Jan 13. pii: S0002-9394(22)00006.
    PubMed     Abstract available
    
    
    
38. XIONG R, Yuan Y, Zhu Z, Wu Y, et al
    Micronutrients and Diabetic Retinopathy: Evidence from The National Health and Nutrition Examination Survey and a Meta-analysis.
    Am J Ophthalmol. 2022 Jan 13. pii: S0002-9394(22)00005.
    PubMed     Abstract available
    
    
    December 2021
39. TSUBOI K, You QS, Guo Y, Wang J, et al
    Association between fluid volume in inner nuclear layer and visual acuity in diabetic macular edema.
    Am J Ophthalmol. 2021 Dec 20. pii: S0002-9394(21)00649.
    PubMed     Abstract available
    
    
    November 2021
40. AHMED I, Pradeep T, Goldberg MF, Liu TYA, et al
    Non-Mydriatic Ultra-Widefield Fundus Photography in a Hematology Clinic Shows Utility for Screening of Sickle Cell Retinopathy.
    Am J Ophthalmol. 2021 Nov 12. pii: S0002-9394(21)00576.
    PubMed     Abstract available
    
    
    October 2021
41. WASZCZYKOWSKA A, Zmyslowska A, Bartosiewicz K, Studzian M, et al
    Reduced Corneal Sensitivity with Neuronal Degeneration is a Novel Clinical Feature in Wolfram Syndrome.
    Am J Ophthalmol. 2021 Oct 25. pii: S0002-9394(21)00505.
    PubMed     Abstract available
    
    
    September 2021
42. PETERS KS, Rivera E, Warden C, Harlow PA, et al
    Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy.
    Am J Ophthalmol. 2021 Sep 26. pii: S0002-9394(21)00478.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.